Drugs / Pulsatile gonadotropin-releasing hormone (GnRH)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00296465 | Feb → Nov 2005 | female infertility | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pulsatile gonadotropin-releasing hormone (GnRH) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00296465 ↗ |
| Route | Intravenous | “administered either subcutaneously (SC) or intraveneously (IV) as specified” NCT00296465 ↗ |
| Route | Subcutaneous | “administered either subcutaneously (SC) or intraveneously (IV) as specified” NCT00296465 ↗ |